The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.
De Sanctis V, Soliman A, Tzoulis P, Daar S, Kattamis A, Delaporta P, Karimi M, Yassin MA, Zarei T, Saki F, Sapunarova K, Banchev A, Galati MC, Raiola G, Messina G, Campisi S, Kattamis C.
De Sanctis V, et al. Among authors: kattamis c, kattamis a.
Acta Biomed. 2022 May 11;93(2):e2022162. doi: 10.23750/abm.v93i2.12056.
Acta Biomed. 2022.
PMID: 35546014
Free PMC article.